GSK shares surge as the drugmaker raises its 2031 sales target to over £40bn, boosts dividends, and announces a £2bn share buyback plan.
European shares were flat in early trade on Wednesday, as gains led by healthcare stocks following drugmaker Novo Nordisk’s ...
UHAPO successfully organized the third edition of The Cancer Conclave 2025, a virtual gathering of leading oncologists, ...
GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, ...